DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc.
Stage unknownSouth San Francisco, CABiotechnology
Facts
Financing history
2 rounds
- Jun 10, 2026Form D equity offering · $75.0M (form d sold) · 16 investorsFact SEC EDGAR Form D data sets (quarterly) · “Lycia Therapeutics, Inc. filed Form D: $75,000,000 sold of $75,000,000, Biotechnology”
- Apr 26, 2024Form D equity offering · $107M (form d sold) · 16 investorsFact SEC EDGAR Form D data sets (quarterly) · “Lycia Therapeutics, Inc. filed Form D: $106,600,004 sold of $106,600,004, Biotechnology”
Investors on record
2 edges
- Inspired Capital Partners, LLC board only, Ming Fang (strongly supported) Inference sec.gov
- Versant Venture Management, LLC board only, Clare Ozawa (strongly supported) Inference sec.gov
People
2 officers, 7 directors
- Aetna Wun Trombley Executive Officer/Director sec.gov
- AMY Bachrodt Executive Officer sec.gov
- Ming Fang Director Inference
- TIM Anderson Director Fact
- William Rieflin Director Fact
- Clare Ozawa Director Inference
- Laurent Fischer Director Fact
- Ming Fang Director Fact
- Andrew Gottesdiener Director Fact
Timeline
2
- Jun 25, 2026Lycia Therapeutics, Inc. filed Form D: $75,000,000 sold of $75,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- May 23, 2024Lycia Therapeutics, Inc. filed Form D: $106,600,004 sold of $106,600,004, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
29 observations
Every observation on this company
- Entity type: Corporation Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $75.0M Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $107M May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $75.0M Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $107M May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-06-10 Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-04-26 May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 16 Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 16 May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080 Jun 25, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080 May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2019 May 23, 2024 Fact SEC EDGAR Form D data sets (quarterly)